Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,381 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 488
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +31.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05685602	CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer	suspended	Phase 1	43	National Cancer Institute (NCI)NIH	1	Sep 9, 2026	clinicaltrials
NCT04158635	Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer	suspended	Phase 1	21	City of Hope Medical CenterOTHER	1	Jun 15, 2026	clinicaltrials